Dasatinib Impurity 51 | CAS 102568-34-3 - Request Quote
Dasatinib Impurity 51
| SZ CAT No: | SZ-D018077 |
| CAS No | 102568-34-3 |
| Mol.F. | C9H11NO4S : Na |
| Mol.Wt. | 229.3 : 23.0 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 76382-58-6 (free base) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dasatinib Impurity 51 is chemically 4-Acetamido-3-methylbenzenesulfonic acid, sodium salt. Dasatinib Impurity 51 is supplied with detailed characterization data compliant with regulatory guideline. Dasatinib Impurity 51 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dasatinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 102568-34-3
Purchase 102568-34-3
Order 102568-34-3
Enquire 102568-34-3
price of 102568-34-3
102568-34-3 Supplier
102568-34-3 Manufacturer
102568-34-3 Exporter
buy high quality Dasatinib Impurity 51
Purchase Dasatinib Impurity 51
Dasatinib Impurity 51 suppliers
Dasatinib Impurity 51 manufacturers
Dasatinib Impurity 51 price
Order Dasatinib Impurity 51
Enquire Dasatinib Impurity 51
Dasatinib Impurity 51 cost
Dasatinib Impurity 51 Supplier
Dasatinib Impurity 51 Distributor
Dasatinib Impurity 51 for Method Validation
Dasatinib Reference Standard
Dasatinib Impurity 51 for ANDA Filing
Dasatinib Impurity 51 for Forced Degradation Studies
Dasatinib Impurity 51 Identification Standards
Dasatinib Impurity 51 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


